儿童变应性支气管肺曲霉病1例

Abstract
Figure/Table
References
Related Citation (15)

[1]	Dhooria S, Kumar P, Saikia B, et al. Prevalence of aspergillus sensitisation in pulmonary tuberculosis-related fibrocavitary disease[J]. Int J Tuberc Lung Dis, 2014, 18(7):850-855.
[2]	Everaerts S, Lagrou K, Dubbeldam A, et al. Sensitization to aspergillus fumigatus as a risk factor for bronchiectasis in COPD[J]. Int J Chron Obstruct Pulmon Dis, 2017, 12:2629-2638.
[3]	中华医学会呼吸病学分会哮喘学组. 变应性支气管肺曲霉病诊治专家共识(2022年修订版)[J]. 中华结核和呼吸杂志, 2022, 45(12):1169-1179.
[4]	Chetty A, Bhargava S, Jain R K. Allergic bronchopulmonary aspergillosis in Indian children with bronchial asthma[J]. Ann Allergy, 1985, 54(1):46-49.
[5]	中华医学会儿科学分会呼吸学组, 中华医学会儿科学分会呼吸学组疑难少见病协作组, 国家呼吸系统疾病临床医学研究中心, 等. 儿童变应性支气管肺曲霉病诊治专家共识[J]. 中华实用儿科临床杂志, 2022, 37(22):1688-1693.
[6]	Agarwal R, Muthu V, Sehgal I S, et al. Allergic bronchopulmonary aspergillosis[J]. Clin Chest Med, 2022, 43(1):99-125.
[7]	Singh S I, Agarwal R. Pulse methylprednisolone in allergic bronchopulmonary aspergillosis exacerbations[J]. Eur Respir Rev, 2014, 23(131):149-152.
[8]	Cohen-Cymberknoh M, Blau H, Shoseyov D, et al. Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis[J]. J Cyst Fibros, 2009, 8(4):253-257.
[9]	Voskamp A L, Gillman A, Symons K, et al. Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis[J]. J Allergy Clin Immunol Pract, 2015, 3(2):192-199.
[10]	Fukushima C, Matsuse H, Obase Y, et al. Liposomal amphotericin B fosters the Corticosteroids' anti-inflammatory effect on murine allergic bronchopulmonary aspergillosis model airways[J]. Inflammation, 2019, 42(6):2065-2071.
[11]	Godet C, Meurice J C, Roblot F, et al. Efficacy of nebulised liposomal amphotericin B in the attack and maintenance treatment of ABPA[J].Eur Respir J,2012, 39(5):1261-1263.
[12]	Godet C, Couturaud F, Marchand-Adam S, et al. Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial[J]. Eur Respir J, 2022, 59(6):2102218.
[13]	Jat K R, Vaidya P C, Mathew J L, et al. Childhood allergic bronchopulmonary aspergillosis[J]. Lung India, 2018, 35(6):499-507.
[14]	Harada M, Imokawa S, Miwa S, et al.Chronic pulmonary aspergillosis may cause eosinophilic granulomatosis with polyangiitis via allergic bronchopulmonary aspergillosis[J]. Oxford Medical Case Reports, 2019, 2019(2):126.
[15]	Denning D W, O'Driscoll B R, Hogaboam C M, et al. The link between fungi and severe asthma: a summary of the evidence[J]. Eur Respir J, 2006, 27(3):615-626.